pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

1,019 catalysts · 3,603 8k filing · 1,776 grant · 1,000 device adverse event · 852 approval · 642 device 510k · 585 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 30 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×type: recall×from 2026-02-03×clear all
type
  • 8k filing3,603
  • grant1,776
  • device adverse event1,000
  • approval852
  • device 510k642
  • earnings585
device pma
493
  • device recall198
  • phase 2 completion172
  • recall167
  • therapy area

    no tagged catalysts yet

    Week of Feb 2, 2026

    50
    ›Feb 3, 2026approval207d agoATELVIA (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

    Sponsor: APIL. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoRECLAST (ZOLEDRONIC ACID) — FDA approvalZOLEDRONIC ACID

    Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS

    full page →ZOLEDRONIC ACID →fda approvals ↗
    ›Feb 3, 2026approval207d agoDYNA-HEX 4 (CHLORHEXIDINE GLUCONATE) — FDA approvalCoorg Instituite of Dental Sciences

    Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoFOSAMAX (ALENDRONATE SODIUM) — FDA approvalALENDRONATE SODIUM

    Sponsor: ORGANON. Form: TABLET. Route: ORAL

    full page →ALENDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: SUN PHARM. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: SUN PHARM. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →ALENDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval207d agoPREGABALIN — FDA approvalPREGABALIN

    Sponsor: MSN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →PREGABALIN →fda approvals ↗
    ›Feb 3, 2026approval207d agoSELENIOUS ACID — FDA approvalRK Pharma Inc

    Sponsor: KINDOS. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoVYKOURA (LEUCOVORIN CALCIUM) — FDA approvalLEUCOVORIN CALCIUM

    Sponsor: AVYXA HOLDINGS. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS

    full page →LEUCOVORIN CALCIUM →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX INC. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval207d agoDYNA-HEX 2 (CHLORHEXIDINE GLUCONATE) — FDA approvalCoorg Instituite of Dental Sciences

    Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

    Sponsor: NOVITIUM PHARMA. Form: SOLUTION. Route: ORAL

    full page →ALENDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: ORBION PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoBINOSTO (ALENDRONATE SODIUM) — FDA approvalOrganon & Co.

    Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval207d agoSTIVARGA (REGORAFENIB) — FDA approvalBayer AG

    Sponsor: BAYER HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoDOXORUBICIN HYDROCHLORIDE — FDA approvalBAXTER INTERNATIONAL INC

    Sponsor: QILU PHARM HAINAN. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoACTONEL (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

    Sponsor: APIL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval207d agoFOSAMAX PLUS D (ALENDRONATE SODIUM) — FDA approval(alendronate sodium + cholecalciferol)

    Sponsor: ORGANON LLC. Form: TABLET. Route: ORAL

    full page →(alendronate sodium + cholecalciferol) →fda approvals ↗
    ›Feb 3, 2026approval207d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: NANG KUANG PHARM CO. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 4, 2026approval206d agoATROPINE SULFATE — FDA approvalATROPINE SULFATE

    Sponsor: ACCORD HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS

    full page →ATROPINE SULFATE →fda approvals ↗
    ›Feb 4, 2026approval206d agoCARBOPLATIN — FDA approvalOncotelic Therapeutics, Inc.

    Sponsor: QILU PHARM HAINAN. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 4, 2026recall206d agoHaleon US Holdings LLC recall (Cls III)

    parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL), Distributed by Haleon, Warren, NJ 07059. NDC 0135-0651-02 — Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles. — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 4, 2026recall206d agoBaxter Healthcare Corporation recall (Cls II)Baxter Healthcare Corp

    Sterile Water for Irrigation, 250 mL, Single-Dose Plastic Bottle, Rx Only, Baxter Healthcare Corporation Deerfield, IL 60015 NDC: 0338-0004-02. — Reason: Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 4, 2026recall206d agoNOVADOZ PHARMACEUTICALS LLC recall (Cls III)Novadoz Pharmaceuticals LLC

    Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72 — Reason: Failed Impurities/Degradation Specifications — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 4, 2026recall206d agoGreenstone Llc recall (Cls II)Greenstone LLC

    methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2 — Reason: Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil. — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 4, 2026recall206d agoSato Pharmaceutical Co., Ltd recall (Cls II)TAKEDA PHARMACEUTICAL CO LTD

    INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01 — Reason: Failed Disintegration Specifications: above the time expected. — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 5, 2026approval205d agoAZTREONAM — FDA approvalAZTREONAM

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →AZTREONAM →fda approvals ↗
    ›Feb 5, 2026approval205d agoFLUOROURACIL — FDA approvalEfudex

    Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

    full page →Efudex →fda approvals ↗
    ›Feb 5, 2026approval205d agoFLUOROURACIL — FDA approvalEfudex

    Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

    full page →Efudex →fda approvals ↗
    ›Feb 5, 2026approval205d agoFLUOROURACIL — FDA approvalExtrovis AG

    Sponsor: KINDOS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 5, 2026approval205d agoNICOTINE POLACRILEX — FDA approvalPL Developments Copiague LLC

    Sponsor: P AND L. Form: GUM, CHEWING. Route: BUCCAL

    full page →fda approvals ↗
    ›Feb 5, 2026approval205d agoNYSTATIN — FDA approvalActavis Mid Atlantic LLC

    Sponsor: STERANCO HLTHCARE. Form: SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 5, 2026approval205d agoFLUOROURACIL — FDA approvalExtrovis AG

    Sponsor: KINDOS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 5, 2026approval205d agoBUMETANIDE — FDA approvalBUMETANIDE

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →BUMETANIDE →fda approvals ↗
    ›Feb 5, 2026approval205d agoFLUOROURACIL — FDA approvalEfudex

    Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INJECTION

    full page →Efudex →fda approvals ↗
    ›Feb 5, 2026approval205d agoFLUOROURACIL — FDA approvalExtrovis AG

    Sponsor: EUGIA PHARMA SPECLTS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 5, 2026approval205d agoFLUOROURACIL — FDA approvalExtrovis AG

    Sponsor: EUGIA PHARMA SPECLTS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ← prev
    page 1 of 21
    next →
    $OGN13.77+0.15%
    $RDY12.19-0.29%
    $RDY12.19-0.29%
    $RDY12.19-0.29%
    $RDY12.19-0.29%
    $RDY12.19-0.29%
    $RDY12.19-0.29%
    $RDY12.19-0.29%
    $RDY12.19-0.29%
    $RDY12.19-0.29%
    $OGN13.77+0.15%
    $OGN13.77+0.15%
    $TAK18.05-0.99%
    $OTLC0.0373-8.80%
    $BAX25.93-2.15%
    $RDY12.19-0.29%